G1 Therapeutics, Inc. (GTHX) Retained Earnings (Accumulated Deficit) USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
G1 Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2016 to 2024.
  • G1 Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$790 M, a 4.03% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$790 M -$30.6 M -4.03% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 -$780 M -$48 M -6.55% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 -$769 M -$70.7 M -10.1% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$751 M -$77.8 M -11.6% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$760 M -$126 M -19.9% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 -$732 M -$148 M -25.2% Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$698 M -$154 M -28.3% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 -$673 M -$171 M -34.1% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 -$634 M -$171 M -37% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 -$584 M -$148 M -34% Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$544 M -$134 M -32.5% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 -$502 M -$103 M -25.8% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 -$463 M -$94.7 M -25.7% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 -$436 M -$99.3 M -29.5% Dec 31, 2020 10-K 2022-02-23
Q3 2020 -$411 M -$109 M -36.3% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 -$399 M -$130 M -48.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$368 M -$130 M -54.3% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$337 M -$122 M -57.1% Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$301 M -$111 M -58.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 -$269 M -$98.7 M -57.9% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$238 M -$88.8 M -59.4% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$214 M -$85.3 M -66.1% Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$190 M -$78.2 M -69.7% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$170 M -$73.9 M -76.5% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$150 M Mar 31, 2018 10-Q 2018-05-03
Q4 2017 -$129 M -$64.1 M -98.7% Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$112 M Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$96.5 M Jun 30, 2017 10-Q 2017-08-09
Q4 2016 -$65 M Dec 31, 2016 10-K 2018-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.